AstraZeneca Building - Search News

AstraZeneca to invest $2.5bn in China

AstraZeneca to build $2.5B research hub in Beijing

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday.

The Financial Times on MSN · 2d

AstraZeneca to invest $2.5bn in China after scandal

AstraZeneca is investing $2.5bn in research and development and manufacturing in Beijing, as the drugmaker tries to move on after a scandal that led to the detention of a top executive in China. The Anglo-Swedish pharmaceutical company has agreed a five-year strategic partnership with the Chinese capital,

Business Insider · 2d

AstraZeneca (AZN) Invests $2.5B in China R&D Hub

AstraZeneca (AZN) said Friday it plans to invest $2.5 billion in a new research and development hub in China as the drugmaker tries to reignite

NBC 7 San Diego3d

AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe

AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British pharmaceutical giant faced local regulators ...

18d

AstraZeneca: A Big Pharma Blue Chip To Buy Now

AstraZeneca boasts a remarkably healthy drug portfolio and a pipeline of promising drugs in clinical development. Read why AZN stock is a Buy.

BioPharma Dive6d

AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal

The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...

Reuters7d

AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy

AstraZeneca to buy EsoBiotec for up to $1 billion Deal aims to enhance cancer cell therapy capabilities AstraZeneca secures global rights to Alteogen's ALT-B4 enzyme AstraZeneca shares up almost ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results